期刊文献+

HPLC法检查米格列奈对映异构体限量 被引量:1

Determination of the enantiomers of mitiglinide by HPLC
下载PDF
导出
摘要 目的:建立高效液相色谱法检查米格列奈对映异构体限量的方法。方法:采用Sumichiral OA-3300(4 mm×250mm,5μm)为手性色谱柱,以正己烷-氯仿-甲醇-三氟醋酸(50∶48∶2∶0.5)为流动相,检测波长为259 nm,流速为1 mL/min。结果:米格列奈与对映异构体达到了较好的分离,其分离度为1.9,对映异构体的最小检出量为30 ng;对映异构体峰面积与浓度线性关系良好,回归方程为A=2.593 4×103c+2.672×102(r=0.999 7,n=5)。结论:该法快速、准确,可用于米格列奈对映异构体的检查与控制。 Aim:To establish an HPLC method to determine the contents of the enantiomers of mitiglinide. Methods: The chromatographic separation of the enantiomers of mitiglinide was performed on a Sumichiral OA-3300 column (4 mm×250 mm, 5 μm) with hexane-chloroform-methanol-trifluoroacetic (50 : 48 : 2 : 0.5) as the mobile phase and the flow rate of 1.0 mL/min. The elution was monitored at the wavelength of 259 nm. Results: The enantiomers were separated with the resolution of 1.9. The limit of detection was 30 ng. There existed good liner relationship between the peak area and the response with the calibatration equation of A = 2. 593 4×10^3 c + 2. 672×10^2 ( r = 0. 999 7, n = 5). Conclusion : The established method is quick, accurate and can be used for the determination and control of the enantiomers of mitiglinide.
作者 张根元
出处 《中国药科大学学报》 CAS CSCD 北大核心 2007年第6期527-529,共3页 Journal of China Pharmaceutical University
关键词 米格列奈 对映异构体 高效液相色谱法 mitiglinide enantiomers HPLC
  • 相关文献

参考文献7

  • 1Toshiaki Y, Takashi Y,Hiroshi H, et al. Preparation of optical succinic acid derivatives.Ⅱ. Efficient and practical synthesis of KAD-1299[J]. Chem Pharm Bull, 1998, 46(2) :337 - 340.
  • 2Kiyoshi I, Kazuyasu M, Makoto M, et al. Absence ot exacerbation of myocardial stunning in anesthetized dogs treated with KAD-1299, a novel hypoglycemic agent[J]. Eur J Pharmacol, 2001, 431(3) : 331 - 338.
  • 3Yasuhiro S, Tohru G, Tadao S, et al. The effects of mitiglinide KAD-1299, a new anti-diabetic drag, on ATP-sensilive K^+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide[J]. Eur J Pharmacol, 2001, 431(1 ) : 119 - 125.
  • 4Mitiglinide calcium hydrate [J]. Drug of the Future, 2000,25 (10): 1 034- 1 042.
  • 5Yamaguchi T, Yanagi T, Okari H, et al. Preparation of optically active succinic acid derivative.Ⅲ. Regioselective condensation reactions of optically active 2-subtituted uccinic acids with diimidazolide[J]. Pharm J, 1998,118(6) :248 - 255.
  • 6邢玉仁,赵国敏,刘燕.高效液相色谱法直接拆分米格列奈对映体[J].药物分析杂志,2006,26(7):1017-1018. 被引量:5
  • 7苏国强,柴雨柱,纪安成,朱兰,郭涤亮.米格列奈的合成方法研究[J].中国药科大学学报,2006,37(1):86-87. 被引量:7

二级参考文献3

  • 1勒库弗JP 弗吉尔C 苏维JC.制备取代的全氧化异吲哚的方法[P].中国,98806779.X[P].2003—05-14.
  • 2Chikusa Y, Fujimoto T,Ikunaka M, et al. (S)-3-Methyl-2-phenylbutylamine, a versatile agent to resolve chiral, racemic carboxylic acids[J]. Org Proc Res Dev, 2002,6(3) :291 - 296.
  • 3Yamaguchi T, Yanagi T,Hokari H, et al. Preparation of optically active succinic acid derivatives.Ⅰ.optical resolution of 2-benzyl-3-(cis-hexahydroisoindolin-2-yl-carbonyl )-propionic acid [J].Chem Pharm Bull,1997,45(9):1518-1520.

共引文献10

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部